EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment

Yali Cheng iD, Youting Dong iD, Bingyi Yang iD, Weiwei Shan iD, Yu Xue iD, Xiaojun Chen iD

Journal of Gynecologic Oncology · 2025

DOI: 10.3802/jgo.2025.36.e111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Yali Cheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Endometrial Hyperplasia, Endometrial Neoplasms, Fertility Preservation, Carcinoma, Endometrioid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Technology R&D Program of China, Clinical Research Plan of SHDC, Clinical Research Project of the Obstetrics and Gynecology Hospital of Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To explore the characteristics of pregnancy outcomes in patients with early-stage endometrioid endometrial cancer (EEC) and endometrial atypical hyperplasia (EAH) after successful fertility-sparing treatment. METHODS: This was a retrospective, single-center analysis of 481 patients with EEC/EAH who desired to conceive after successful fertility-sparing treatment from January 2015 to June 2023. Pregnancy outcomes across reproductive methods were compared. RESULTS: The pregnancy rate was 58.24% and the live birth rate was 48.65% in patients with EAH/EEC after successful fertility-preserving treatment. An age ≥35 years, BMI ≥25 kg/m², and hypertension were independent risk factors for failure of pregnancy. Higher pregnancy (65.77% and 63.64%) and live birth (53.08% and 48.86%) rates were achieved in the in vitro fertilization and embryo transfer (IVF-ET) and ovulation induction group than in the natural conception group (47.68% and 35.10%, respectively). The incidence of threatened abortion (56.52%), cervical insufficiency (5.58%), and placenta accrete/increta (11.15%) appeared to be numerically higher in patients with EAH/EEC than in epidemiological data. More than 5 times of hysteroscopic evaluation was an independent risk factor for placenta accreta/increta. CONCLUSION: Assisted reproductive technology including IVF-ET and ovulation induction might be preferred for patients with EEC/EAH after successful fertility-sparing treatment to achieve a relatively better pregnancy outcome, though IVF-ET has a higher incidence risk of threatened abortion, preterm birth and placenta accreta/increta. Obstetricians should be prepared for the treatment of threatened abortion, cervical insufficiency, and placenta accreta/increta in patients with EEC/EAH once they become pregnant, especially in those receiving more than 5 times of hysteroscopic evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial HyperplasiaEndometrial NeoplasmsFertility PreservationCarcinoma, EndometrioidPregnancy ComplicationsHumansFemalePregnancyRetrospective StudiesAdultPregnancy OutcomeFertilization in VitroPregnancy RateOvulation InductionEmbryo TransferRisk Factors

Stichwörter der Autor:innen

Endometrial Atypical HyperplasiaEndometrial CancerFertility-Preserving TreatmentObstetric Labor ComplicationsPregnancy Outcome

Autor:innen und Institutionen

  • Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Fudan University, Shanghai, China.
  • Department of Obstetrics and Gynecology, Shanghai 10th People's Hospital, Tongji University School of Medicine, Shanghai, China. xiaojunchen2013@sina.com.

ORCID-Profile: Yali Cheng, Youting Dong, Bingyi Yang, Weiwei Shan, Yu Xue, Xiaojun Chen

Förderung

  • National Key Technology R&D Program of China
  • Clinical Research Plan of SHDC
  • Clinical Research Project of the Obstetrics and Gynecology Hospital of Fudan University

Zitieren

APA

Cheng, Y., Dong, Y., Yang, B., Shan, W., Xue, Y., & Chen, X. (2025). Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e111

Vancouver

Cheng Y, Dong Y, Yang B, Shan W, Xue Y, Chen X. Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e111

BibTeX
@article{Cheng2025,
  author = {Cheng, Yali and Dong, Youting and Yang, Bingyi and Shan, Weiwei and Xue, Yu and Chen, Xiaojun},
  title = {Pregnancy complications and outcomes in patients with early endometrial cancer or atypical hyperplasia after fertility-sparing treatment},
  journal = {Journal of Gynecologic Oncology},
  year = {2025},
  doi = {10.3802/jgo.2025.36.e111}
}
Kostenlos starten →